Granted Patent B2

US 12,233,004 · App. 18/499,079 · Granted Feb 25, 2025

Inventors: Thomas A. Silvestrini (Alamo, CA); Eugene De Juan, Jr. (Brisbane, CA)

Assignee: Alcon Inc.

A61F9/00781A61F2210/0019

Abstract

Claims (32)

1. A method of delivering an implant into an eye, comprising:

forming an incision in the eye;

inserting the implant through the incision into the eye; and

positioning the implant in the eye such that a portion of the implant is in fluid communication with an anterior chamber of the eye and another portion of the implant is in fluid communication with the supraciliary space of the eye,

wherein the implant is configured to transition from a curved shape to a less curved shape within the eye.

2. The method of claim 1 , wherein the portion of the implant in fluid communication with the anterior chamber is a flow entry pathway of the implant.

3. The method of claim 1 , wherein the other portion of the implant in fluid communication with the supraciliary space is a flow exit pathway of the implant.

4. The method of claim 1 , further comprising deforming adjacent eye tissue to form a tented volume beneath the sclera of the eye in response to the implant transitioning from the curved shape to the less curved shape.

5. The method of claim 4 , wherein a stiffness of the implant is greater than a stiffness of the adjacent eye tissue surrounding the supraciliary space.

6. The method of claim 1 , wherein the implant comprises a fluid passageway, wherein the fluid passageway is configured to drain aqueous humor from the anterior chamber toward the suprachoroidal space when the implant is positioned within the eye.

7. The method of claim 1 , further comprising releasing the implant from a delivery instrument used to insert the implant into the eye, wherein the implant is configured to transition from the curved shape to the less curved shape after being released from the delivery instrument.

8. The method of claim 1 , wherein the implant transitions from the curved shape to the less curved shape within the supraciliary space and forms a chord relative to a curvature of the supraciliary space.

9. The method of claim 8 , wherein the chord is a straight chord.

10. The method of claim 8 , wherein the chord is a curved chord.

11. A method of treating an eye, comprising:

forming an incision in the eye;

inserting an implant through the incision into the eye, wherein the implant comprises a fluid passageway;

passing the implant along a pathway from the anterior chamber of the eye into the suprachoroidal space; and

positioning the implant such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space.

12. The method of claim 11 , further comprising applying a force on the ciliary body with the implant to reduce aqueous outflow from the ciliary body.

13. The method of claim 12 , wherein applying the force on the ciliary body elicits an increase in prostaglandin production by the ciliary body.

14. The method of claim 12 , wherein applying the force on the ciliary body with the implant displaces at least a portion of the ciliary body.

15. The method of claim 12 , wherein applying the force on the ciliary body with the implant does not displace the ciliary body.

16. A method of delivering an implant into an eye, comprising:

forming an incision in the eye;

inserting the implant through the incision into the eye;

forming an opening to separate a portion of a ciliary body of the eye from the sclera of the eye using a delivery instrument removably coupled to the implant; and

positioning the implant through the opening and between the sclera and the ciliary body such that the implant is configured to drain aqueous humor from the anterior chamber of the eye toward the suprachoroidal space, wherein the implant is configured to undertake a shape change within the eye.

17. The method of claim 16 , wherein the implant is configured to transition from a first shape to a second shape, wherein the second shape is less curved than the first shape.

18. The method of claim 17 , wherein the implant is straight when in the second shape.

19. The method of claim 17 , wherein the implant is curved when in the second shape.

20. The method of claim 16 , further comprising releasing the implant from the delivery instrument, wherein the implant is configured to undertake the shape change when released from the delivery instrument.

Assignments (3)

Continuity (10)

References Cited (400)